Clinical Overview of Hypereosinophilic Syndromes

Immunology and Allergy Clinics of North America

Volumn 27, Issue 3, 2007, Pages 333-355

  Sheikh, Javed ^a   Weller, Peter F ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; DISEASE CLASSIFICATION; EOSINOPHILIA; HEMATOLOGIC DISEASE; HUMAN; HYPEREOSINOPHILIC SYNDROME; LIFE EXPECTANCY; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; REVIEW;

GASTROINTESTINAL DISEASES; HEART DISEASES; HUMANS; HYPEREOSINOPHILIC SYNDROME; LIVER DISEASES; LUNG DISEASES; MYELOPROLIFERATIVE DISORDERS; NERVOUS SYSTEM DISEASES; SKIN DISEASES;

EID: 34548509941     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2007.07.007     Document Type: Review

References (111)

1. Bain B.J. Hypereosinophilia. Curr Opin Hematol 7 1 (2000) 21-25
2. Roufosse F., Cogan E., and Goldman M. The hypereosinophilic syndrome revisited. Annu Rev Med 54 (2003) 169-184
3. Weller P.F., and Bubley G.J. The idiopathic hypereosinophilic syndrome. Blood 83 10 (1994) 2759-2779
4. Klion A.D., Bochner B.S., Gleich G.J., et al. Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report. J Allergy Clin Immunol 117 6 (2006) 1292-1302
5. Roufosse F., Goldman M., and Cogan E. Hypereosinophilic syndrome: lymphoproliferative and myeloproliferative variants. Semin Respir Crit Care Med 27 2 (2006) 158-170
6. Spry C. Eosinophils. A comprehensive review and guide to the scientific and medical literature (1988), Oxford Medical Publications, Oxford (UK)
7. Hardy W.R., and Anderson R.E. The hypereosinophilic syndromes. Ann Intern Med 68 6 (1968) 1220-1229
8. Chusid M.J., Dale D.C., West B.C., et al. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore) 54 1 (1975) 1-27
9. Fauci A.S., Harley J.B., Roberts W.C., et al. NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med 97 1 (1982) 78-92
10. Katz H.T., Haque S.J., and Hsieh F.H. Pediatric hypereosinophilic syndrome (HES) differs from adult HES. J Pediatr 146 1 (2005) 134-136
11. Rives S., Alcorta I., Toll T., et al. Idiopathic hypereosinophilic syndrome in children: report of a 7-year-old boy with FIP1L1-PDGFRA rearrangement. J Pediatr Hematol Oncol 27 12 (2005) 663-665
12. Spry C.J., and Tai P.C. Studies on blood eosinophils. II. Patients with Loffler's cardiomyopathy. Clin Exp Immunol 24 3 (1976) 423-434
13. Peters M.S., Gleich G.J., Dunnette S.L., et al. Ultrastructural study of eosinophils from patients with the hypereosinophilic syndrome: a morphological basis of hypodense eosinophils. Blood 71 3 (1988) 780-785
14. Sokol R.J., Hudson G., Brown M.J., et al. Hypereosinophilic syndrome: case report and morphometric study. Acta Haematol 79 2 (1988) 107-111
15. Dvorak A. Subcellular morphology and biochemistry of eosinophils. In: Harris J. (Ed). Blood cell biochemistry: megakaryocytes, platelets, macrophages and eosinophils (1990), Plenum, London (UK) 237
16. Ackerman G.A. Eosinophilic leukemia: a morphologic and histochemical study. Blood 24 (1964) 372-388
17. Bain B.J. Relationship between idiopathic hypereosinophilic syndrome, eosinophilic leukemia, and systemic mastocytosis. Am J Hematol 77 1 (2004) 82-85
18. Schooley R.T., Flaum M.A., Gralnick H.R., et al. A clinicopathologic correlation of the idiopathic hypereosinophilic syndrome. II. Clinical manifestations. Blood 58 5 (1981) 1021-1026
19. Dale D.C., Hubert R.T., and Fauci A. Eosinophil kinetics in the hypereosinophilic syndrome. J Lab Clin Med 87 3 (1976) 487-495
20. Flaum M.A., Schooley R.T., Fauci A.S., et al. A clinicopathologic correlation of the idiopathic hypereosinophilic syndrome. I. Hematologic manifestations. Blood 58 5 (1981) 1012-1020
21. Spry C.J., Davies J., Tai P.C., et al. Clinical features of fifteen patients with the hypereosinophilic syndrome. Q J Med 52 205 (1983) 1-22
22. Lefebvre C., Bletry O., Degoulet P., et al. [Prognostic factors of hypereosinophilic syndrome. Study of 40 cases]. Ann Med Interne (Paris) 140 4 (1989) 253-257 [in French]
23. Brockington I.F., and Olsen E.G. Eosinophilia and endomyocardial fibrosis. Postgrad Med J 48 566 (1972) 740-741
24. Parrillo J.E., Borer J.S., Henry W.L., et al. The cardiovascular manifestations of the hypereosinophilic syndrome. Prospective study of 26 patients, with review of the literature. Am J Med 67 4 (1979) 572-582
25. Naito H., Nakatsuka M., Yuki K., et al. [Giant left ventricular thrombi in the hypereosinophilic syndrome: report of two cases]. J Cardiogr 16 2 (1986) 475-488 [in Japanese]
26. Hendren W.G., Jones E.L., and Smith M.D. Aortic and mitral valve replacement in idiopathic hypereosinophilic syndrome. Ann Thorac Surg 46 5 (1988) 570-571
27. Tanino M., Kitamura K., Ohta G., et al. Hypereosinophilic syndrome with extensive myocardial involvement and mitral valve thrombus instead of mural thrombi. Acta Pathol Jpn 33 6 (1983) 1233-1242
28. Davies J., Spry C.J., Sapsford R., et al. Cardiovascular features of 11 patients with eosinophilic endomyocardial disease. Q J Med 52 205 (1983) 23-39
29. Spry C.J., Take M., and Tai P.C. Eosinophilic disorders affecting the myocardium and endocardium: a review. Heart Vessels Suppl 1 (1985) 240-242
30. Jasim K.A., Layzell T., and McCulloch A.J. Loffler's eosinophilic endocarditis following carcinoma of the thyroid gland. Br J Clin Pract 44 12 (1990) 785-786
31. Keiser G., Ruttner J.R., Wacker H., et al. [Hypereosinophilic syndrome with Loffler's endocarditis in Hodgkin's disease (author's transl)]. Dtsch Med Wochenschr 99 37 (1974) 1820-1822 1827-29 [in German]
32. Andy J.J. Helminthiasis, the hypereosinophilic syndrome and endomyocardial fibrosis: some observations and an hypothesis. Afr J Med Med Sci 12 3-4 (1983) 155-164
33. Butterfield J.H., Leiferman K.M., Abrams J., et al. Elevated serum levels of interleukin-5 in patients with the syndrome of episodic angioedema and eosinophilia. Blood 79 3 (1992) 688-692
34. Ohmoto K., and Yamamoto S. Angioedema after interferon therapy for chronic hepatitis C. Am J Gastroenterol 96 4 (2001) 1311-1312
35. Gleich G.J., Schroeter A.L., Marcoux J.P., et al. Episodic angioedema associated with eosinophilia. N Engl J Med 310 25 (1984) 1621-1626
36. Banerji A., Weller P.F., and Sheikh J. Cytokine-associated angioedema syndromes including episodic angioedema with eosinophilia (Gleich's syndrome). Immunol Allergy Clin North Am 26 4 (2006) 769-781
37. Roche-Lestienne C., Lepers S., Soenen-Cornu V., et al. Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogenetics. Leukemia 19 5 (2005) 792-798
38. Chikama R., Hosokawa M., Miyazawa T., et al. Nonepisodic angioedema associated with eosinophilia: report of 4 cases and review of 33 young female patients reported in Japan. Dermatology 197 4 (1998) 321-325
39. Shimasaki A.K. [Five cases of nonepisodic angioedema with eosinophilia]. Rinsho Ketsueki 42 8 (2001) 639-643 [in Japanese]
40. Mizukawa Y., and Shiohara T. The cytokine profile in a transient variant of angioedema with eosinophilia. Br J Dermatol 144 1 (2001) 169-174
41. Kazmierowski J.A., Chusid M.J., Parrillo J.E., et al. Dermatologic manifestations of the hypereosinophilic syndrome. Arch Dermatol 114 4 (1978) 531-535
42. Leiferman K.M., O'Duffy J.D., Perry H.O., et al. Recurrent incapacitating mucosal ulcerations. A prodrome of the hypereosinophilic syndrome. JAMA 247 7 (1982) 1018-1020
43. Akahoshi M., Hoshino S., Teramura M., et al. [Recurrent oral and genital ulcers as the prodrome of the hypereosinophilic syndrome: report of a probable case]. Nippon Naika Gakkai Zasshi 76 3 (1987) 421-424 [in Japanese]
44. Moore P.M., Harley J.B., and Fauci A.S. Neurologic dysfunction in the idiopathic hypereosinophilic syndrome. Ann Intern Med 102 1 (1985) 109-114
45. Wichman A., Buchthal F., Pezeshkpour G.H., et al. Peripheral neuropathy in hypereosinophilic syndrome. Neurology 35 8 (1985) 1140-1145
46. Lupo I., Daniele O., Raimondo D., et al. Peripheral neuropathy in the hypereosinophilic syndrome: a case report. Eur Neurol 29 5 (1989) 269-272
47. Bell D., Mackay I.G., and Pentland B. Hypereosinophilic syndrome presenting as peripheral neuropathy. Postgrad Med J 61 715 (1985) 429-432
48. Dorfman L.J., Ransom B.R., Forno L.S., et al. Neuropathy in the hypereosinophilic syndrome. Muscle Nerve 6 4 (1983) 291-298
49. Werner R.A., and Wolf L.L. Peripheral neuropathy associated with the hypereosinophilic syndrome. Arch Phys Med Rehabil 71 6 (1990) 433-435
50. Guidetti D., Gemignani F., Terenziani S., et al. Peripheral neuropathy associated with hypereosinophilia. Acta Neurol Belg 91 1 (1991) 12-19
51. Monaco S., Lucci B., Laperchia N., et al. Polyneuropathy in hypereosinophilic syndrome. Neurology 38 3 (1988) 494-496
52. Martin-Gonzalez E., Yebra M., Garcia-Merino A., et al. Neurologic dysfunction in the idiopathic hypereosinophilic syndrome. Ann Intern Med 104 3 (1986) 448-449
53. Grisold W., and Jellinger K. Multifocal neuropathy with vasculitis in hypereosinophilic syndrome. An entity or drug-induced effect?. J Neurol 231 6 (1985) 301-306
54. Marolda M., Orefice G., Barbieri F., et al. The idiopathic hypereosinophilic syndrome. Clinical, electrophysiological and histological study of a case. Ital J Neurol Sci 10 1 (1989) 79-84
55. Durack D.T., Sumi S.M., and Klebanoff S.J. Neurotoxicity of human eosinophils. Proc Natl Acad Sci U S A 76 3 (1979) 1443-1447
56. Epstein D.M., Taormina V., Gefter W.B., et al. The hypereosinophilic syndrome. Radiology 140 1 (1981) 59-62
57. Cordier J.F., Faure M., Hermier C., et al. Pleural effusions in an overlap syndrome of idiopathic hypereosinophilic syndrome and erythema elevatum diutinum. Eur Respir J 3 1 (1990) 115-118
58. Hill R., Wang N.S., and Berry G. Hypereosinophilic syndrome with pulmonary vascular involvement. Angiology 35 4 (1984) 238-244
59. Slabbynck H., Impens N., Naegels S., et al. Idiopathic hypereosinophilic syndrome-related pulmonary involvement diagnosed by bronchoalveolar lavage. Chest 101 4 (1992) 1178-1180
60. Winn R.E., Kollef M.H., and Meyer J.I. Pulmonary involvement in the hypereosinophilic syndrome. Chest 105 3 (1994) 656-660
61. Levesque H., Elie-Legrand M.C., Thorel J.M., et al. [Idiopathic hypereosinophilic syndrome with predominant digestive manifestations or eosinophilic gastroenteritis? Apropos of 2 cases]. Gastroenterol Clin Biol 14 6-7 (1990) 586-588 [in French]
62. Scheurlen M., Mork H., and Weber P. Hypereosinophilic syndrome resembling chronic inflammatory bowel disease with primary sclerosing cholangitis. J Clin Gastroenterol 14 1 (1992) 59-63
63. Shah A.M., and Joglekar M. Eosinophilic colitis as a complication of the hypereosinophilic syndrome. Postgrad Med J 63 740 (1987) 485-487
64. Aksnes B., Hammerstrom J., and Kleveland P.M. [Idiopathic hypereosinophilic syndrome. Enterocolitis-a rare manifestation]. Tidsskr Nor Laegeforen 109 24 (1989) 2433-2435 [in Norwegian]
65. Vandewiele I.A., Maeyaert B.M., Van Cutsem E.J., et al. Massive eosinophilic ascites: differential diagnosis between idiopathic hypereosinophilic syndrome and eosinophilic gastroenteritis. Acta Clin Belg 46 1 (1991) 37-41
66. Falade A.G., Darbyshire P.J., Raafat F., et al. Hypereosinophilic syndrome in childhood appearing as inflammatory bowel disease. J Pediatr Gastroenterol Nutr 12 2 (1991) 276-279
67. Croffy B., Kopelman R., and Kaplan M. Hypereosinophilic syndrome. Association with chronic active hepatitis. Dig Dis Sci 33 2 (1988) 233-239
68. Foong A., Scholes J.V., Gleich G.J., et al. Eosinophil-induced chronic active hepatitis in the idiopathic hypereosinophilic syndrome. Hepatology 13 6 (1991) 1090-1094
69. Elouaer-Blanc L., Zafrani E.S., Farcet J.P., et al. Hepatic vein obstruction in idiopathic hypereosinophilic syndrome. Arch Intern Med 145 4 (1985) 751-753
70. Suenaga N., Hayashi F., Miyauhi N., et al. [A case of hypereosinophilic syndrome associated with pulmonary infarction and hepatic vein obstruction (Budd-Chiari syndrome)]. Nihon Kyobu Shikkan Gakkai Zasshi 29 2 (1991) 239-244 [in Japanese]
71. Eugene C., Gury B., Bergue A., et al. [Icterus disclosing pancreatic involvement in idiopathic hypereosinophilic syndrome]. Gastroenterol Clin Biol 8 12 (1984) 966-969 [in French]
72. Chaine G., Davies J., Kohner E.M., et al. Ophthalmologic abnormalities in the hypereosinophilic syndrome. Ophthalmology 89 12 (1982) 1348-1356
73. Binaghi M., Perrenoud F., Dhermy P., et al. [Hypereosinophilic syndrome with ocular involvement]. J Fr Ophtalmol 8 4 (1985) 309-314 [in French]
74. Layzer R.B., Shearn M.A., and Satya-Murti S. Eosinophilic polymyositis. Ann Neurol 1 1 (1977) 65-71
75. Takekawa M., Imai K., Adachi M., et al. Hypereosinophilic syndrome accompanied with necrosis of finger tips. Intern Med 31 11 (1992) 1262-1266
76. Pye M., Pope R., Jones J.H., et al. Eosinophilic polymyositis presenting as a pseudotumour in the hypereosinophilic syndrome. Br J Rheumatol 26 5 (1987) 384-385
77. Peison B., Benisch B., Lim M., et al. Idiopathic hypereosinophilic syndrome with polymyositis. South Med J 81 3 (1988) 403-406
78. Cools J., DeAngelo D.J., Gotlib J., et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 348 13 (2003) 1201-1214
79. Raghavachar A., Fleischer S., Frickhofen N., et al. T lymphocyte control of human eosinophilic granulopoiesis. Clonal analysis in an idiopathic hypereosinophilic syndrome. J Immunol 139 11 (1987) 3753-3758
80. Schrezenmeier H., Thome S.D., Tewald F., et al. Interleukin-5 is the predominant eosinophilopoietin produced by cloned T lymphocytes in hypereosinophilic syndrome. Exp Hematol 21 2 (1993) 358-365
81. Cogan E., Schandene L., Crusiaux A., et al. Brief report: clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. N Engl J Med 330 8 (1994) 535-538
82. Roufosse F., Cogan E., and Goldman M. Recent advances in pathogenesis and management of hypereosinophilic syndromes. Allergy 59 7 (2004) 673-689
83. Simon H.U., Plotz S.G., Dummer R., et al. Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia. N Engl J Med 341 15 (1999) 1112-1120
84. Jovanovic J.V., Score J., Waghorn K., et al. Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia. Blood 109 11 (2007) 4635-4640
85. Klion A.D., Noel P., Akin C., et al. Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness. Blood 101 12 (2003) 4660-4666
86. Vandenberghe P., Wlodarska I., Michaux L., et al. Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias. Leukemia 18 4 (2004) 734-742
87. Griffin J.H., Leung J., Bruner R.J., et al. Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome. Proc Natl Acad Sci U S A 100 13 (2003) 7830-7835
88. Klion A.D., Robyn J., Akin C., et al. Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome. Blood 103 2 (2004) 473-478
89. Pardanani A., Brockman S.R., Paternoster S.F., et al. FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia. Blood 104 10 (2004) 3038-3045
90. Harley J.B., Fauci A.S., and Gralnick H.R. Noncardiovascular findings associated with heart disease in the idiopathic hypereosinophilic syndrome. Am J Cardiol 52 3 (1983) 321-324
91. Rotoli B., Catalano L., Galderisi M., et al. Rapid reversion of Loeffler's endocarditis by imatinib in early stage clonal hypereosinophilic syndrome. Leuk Lymphoma 45 12 (2004) 2503-2507
92. McPherson T., Cowen E.W., McBurney E., et al. Platelet-derived growth factor receptor-alpha-associated hypereosinophilic syndrome and lymphomatoid papulosis. Br J Dermatol 155 4 (2006) 824-826
93. Roufosse F., Schandene L., Sibille C., et al. Clonal Th2 lymphocytes in patients with the idiopathic hypereosinophilic syndrome. Br J Haematol 109 3 (2000) 540-548
94. Brugnoni D., Airo P., Rossi G., et al. A case of hypereosinophilic syndrome is associated with the expansion of a CD3-CD4+ T-cell population able to secrete large amounts of interleukin-5. Blood 87 4 (1996) 1416-1422
95. O'Shea J.J., Jaffe E.S., Lane H.C., et al. Peripheral T cell lymphoma presenting as hypereosinophilia with vasculitis. Clinical, pathologic, and immunologic features. Am J Med 82 3 (1987) 539-545
96. Moraillon I., Bagot M., Bournerias I., et al. [Hypereosinophilic syndrome with pachyderma preceding lymphoma. Treatment with interferon alpha]. Ann Dermatol Venereol 118 11 (1991) 883-885 [in French]
97. Kim C.J., Park S.H., and Chi J.G. Idiopathic hypereosinophilic syndrome terminating as disseminated T-cell lymphoma. Cancer 67 4 (1991) 1064-1069
98. Butterfield J.H. Diverse clinical outcomes of eosinophilic patients with T-cell receptor gene rearrangements: the emerging diagnostic importance of molecular genetics testing. Am J Hematol 68 2 (2001) 81-86
99. Zenone T., Felman P., Malcus C., et al. Indolent course of a patient with hypereosinophilic syndrome associated with clonal T-cell proliferation. Am J Med 107 5 (1999) 509-511
100. Morgan S.J., Prince H.M., Westerman D.A., et al. Clonal T-helper lymphocytes and elevated IL-5 levels in episodic angioedema and eosinophilia (Gleich's syndrome). Leuk Lymphoma 44 9 (2003) 1623-1625
101. Bank I., Amariglio N., Reshef A., et al. The hypereosinophilic syndrome associated with CD4+CD3- helper type 2 (Th2) lymphocytes. Leuk Lymphoma 42 1-2 (2001) 123-133
102. Lin A.Y., Nutman T.B., Kaslow D., et al. Familial eosinophilia: clinical and laboratory results on a U.S. kindred. Am J Med Genet 76 3 (1998) 229-237
103. Klion A.D., Law M.A., Riemenschneider W., et al. Familial eosinophilia: a benign disorder?. Blood 103 11 (2004) 4050-4055
104. Schandene L., Del Prete G.F., Cogan E., et al. Recombinant interferon-alpha selectively inhibits the production of interleukin-5 by human CD4+ T cells. J Clin Invest 97 2 (1996) 309-315
105. Schandene L., Roufosse F., de Lavareille A., et al. Interferon alpha prevents spontaneous apoptosis of clonal Th2 cells associated with chronic hypereosinophilia. Blood 96 13 (2000) 4285-4292
106. Rosenwasser L.J., Schwartz L.B., Sheikh J., et al. Corticosteroid-sparing effects of mepolizumab, an anti-interleukin-5 monoclonal antibody, in patients with hypereosinophilic syndrome. J Allergy Clin Immunol 119 (2007) S160
107. Plotz S.G., Simon H.U., Darsow U., et al. Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis. N Engl J Med 349 24 (2003) 2334-2339
108. Garrett J.K., Jameson S.C., Thomson B., et al. Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. J Allergy Clin Immunol 113 1 (2004) 115-119
109. Pitini V., Teti D., Arrigo C., et al. Alemtuzumab therapy for refractory idiopathic hypereosinophilic syndrome with abnormal T cells: a case report. Br J Haematol 127 5 (2004) 477
110. Sefcick A., Sowter D., DasGupta E., et al. Alemtuzumab therapy for refractory idiopathic hypereosinophilic syndrome. Br J Haematol 124 4 (2004) 558-559
111. Ravoet M., Sibille C., Roufosse F., et al. 6q- is an early and persistent chromosomal aberration in CD3-CD4+ T-cell clones associated with the lymphocytic variant of hypereosinophilic syndrome. Haematologica 90 6 (2005) 753-765